148 related articles for article (PubMed ID: 31926145)
21. Discovery of a series of aminopiperidines as novel iNOS inhibitors.
Le Bourdonnec B; Leister LK; Ajello CA; Cassel JA; Seida PR; O'Hare H; Gu M; Chu GH; Tuthill PA; DeHaven RN; Dolle RE
Bioorg Med Chem Lett; 2008 Jan; 18(1):336-43. PubMed ID: 18024030
[TBL] [Abstract][Full Text] [Related]
22. Screening and Identification of Potential iNOS Inhibitors to Curtail Cervical Cancer Progression: an In Silico Drug Repurposing Approach.
Poleboyina PK; Rampogu S; Doneti R; Pasha A; Poleboyina SM; Bhanothu S; Pasumarthi D; S D A; Kumbhakar D; Lee KW; Pawar SC
Appl Biochem Biotechnol; 2022 Jan; 194(1):570-586. PubMed ID: 34705247
[TBL] [Abstract][Full Text] [Related]
23. The effect of N-nitro-L-arginine and aminoguanidine treatment on changes in constitutive and inducible nitric oxide synthases in the spinal cord after sciatic nerve transection.
Lukacova N; Davidova A; Kolesar D; Kolesarova M; Schreiberova A; Lackova M; Krizanova O; Marsala M; Marsala J
Int J Mol Med; 2008 Apr; 21(4):413-21. PubMed ID: 18360686
[TBL] [Abstract][Full Text] [Related]
24. Effects of nitric oxide synthase inhibitors on systemic hypotension, cytokines and inducible nitric oxide synthase expression and lung injury following endotoxin administration in rats.
Wang D; Wei J; Hsu K; Jau J; Lieu MW; Chao TJ; Chen HI
J Biomed Sci; 1999 Jan; 6(1):28-35. PubMed ID: 9933740
[TBL] [Abstract][Full Text] [Related]
25. L-arginine binding to human inducible nitric oxide synthase: an antisymmetric funnel route toward isoform-specific inhibitors?
Floquet N; Hernandez JF; Boucher JL; Martinez J
J Chem Inf Model; 2011 Jun; 51(6):1325-35. PubMed ID: 21574590
[TBL] [Abstract][Full Text] [Related]
26. iNOS-selective inhibitors for cancer prevention: promise and progress.
Janakiram NB; Rao CV
Future Med Chem; 2012 Nov; 4(17):2193-204. PubMed ID: 23190107
[TBL] [Abstract][Full Text] [Related]
27. Trichloroethylene induce nitric oxide production and nitric oxide synthase mRNA expression in cultured normal human epidermal keratinocytes.
Shen T; Zhu QX; Yang S; Ding R; Ma T; Ye LP; Wang LJ; Liang ZZ; Zhang XJ
Toxicology; 2007 Oct; 239(3):186-94. PubMed ID: 17719164
[TBL] [Abstract][Full Text] [Related]
28. Extensive ligand-based modeling and in silico screening reveal nanomolar inducible nitric oxide synthase (iNOS) inhibitors.
Suaifan GA; Shehadehh M; Al-Ijel H; Taha MO
J Mol Graph Model; 2012 Jul; 37():1-26. PubMed ID: 22609742
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
[TBL] [Abstract][Full Text] [Related]
30. BYK191023 (2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3h-imidazo[4,5-b]pyridine) is an NADPH- and time-dependent irreversible inhibitor of inducible nitric-oxide synthase.
Tiso M; Strub A; Hesslinger C; Kenney CT; Boer R; Stuehr DJ
Mol Pharmacol; 2008 Apr; 73(4):1244-53. PubMed ID: 18178668
[TBL] [Abstract][Full Text] [Related]
31. High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.
Puglisi MA; Cenciarelli C; Tesori V; Cappellari M; Martini M; Di Francesco AM; Giorda E; Carsetti R; Ricci-Vitiani L; Gasbarrini A
J Pathol; 2015 Aug; 236(4):479-90. PubMed ID: 25875314
[TBL] [Abstract][Full Text] [Related]
32. Nitric oxide synthase and structure-based inhibitor design.
Poulos TL; Li H
Nitric Oxide; 2017 Feb; 63():68-77. PubMed ID: 27890696
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture.
Okamoto I; Abe M; Shibata K; Shimizu N; Sakata N; Katsuragi T; Tanaka K
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):716-22. PubMed ID: 10934111
[TBL] [Abstract][Full Text] [Related]
34. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction in vascular smooth muscle cells is mediated via a nitric oxide-dependent mechanism.
Rodríguez A; Fortuño A; Gómez-Ambrosi J; Zalba G; Díez J; Frühbeck G
Endocrinology; 2007 Jan; 148(1):324-31. PubMed ID: 17038553
[TBL] [Abstract][Full Text] [Related]
35. Inducible nitric oxide synthase aggresome formation is mediated by nitric oxide.
Wang T; Xia Y
Biochem Biophys Res Commun; 2012 Sep; 426(3):386-9. PubMed ID: 22960179
[TBL] [Abstract][Full Text] [Related]
36. 1,3,4-Thiadiazole derivatives as selective inhibitors of iNOS versus nNOS: Synthesis and structure-activity dependence.
López-Cara LC; Carrión MD; Entrena A; Gallo MA; Espinosa A; López A; Escames G; Acuña-Castroviejo D; Camacho ME
Eur J Med Chem; 2012 Apr; 50():129-39. PubMed ID: 22336385
[TBL] [Abstract][Full Text] [Related]
37. Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry.
McMillan K; Adler M; Auld DS; Baldwin JJ; Blasko E; Browne LJ; Chelsky D; Davey D; Dolle RE; Eagen KA; Erickson S; Feldman RI; Glaser CB; Mallari C; Morrissey MM; Ohlmeyer MH; Pan G; Parkinson JF; Phillips GB; Polokoff MA; Sigal NH; Vergona R; Whitlow M; Young TA; Devlin JJ
Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1506-11. PubMed ID: 10677491
[TBL] [Abstract][Full Text] [Related]
38. Heteroaromatic-aminomethyl quinolones: potent and selective iNOS inhibitors.
Durón SG; Lindstrom A; Bonnefous C; Zhang H; Chen X; Symons KT; Sablad M; Rozenkrants N; Zhang Y; Wang L; Yazdani N; Shiau AK; Noble SA; Rix P; Rao TS; Hassig CA; Smith ND
Bioorg Med Chem Lett; 2012 Jan; 22(2):1237-41. PubMed ID: 22182498
[TBL] [Abstract][Full Text] [Related]
39. Use of a murine cell line for identification of human nitric oxide synthase inhibitors.
Naureckiene S; Edris W; Ajit SK; Katz AH; Sreekumar K; Rogers KE; Kennedy JD; Jones PG
J Pharmacol Toxicol Methods; 2007; 55(3):303-13. PubMed ID: 16990017
[TBL] [Abstract][Full Text] [Related]
40. Food-related compounds that modulate expression of inducible nitric oxide synthase may act as its inhibitors.
Maldonado-Rojas W; Olivero-Verbel J
Molecules; 2012 Jul; 17(7):8118-35. PubMed ID: 22766803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
